Leukocare

Private

GermanyHealthcare & Life Scienceshttps://www.leukocare.com/

Last Round

VC Round

Jun 23, 2021

Company Overview

Leukocare is a biotechnology company that provides a technology platform for biopharmaceutical formulation development to improve the stability and quality of biologics like vaccines, antibodies, and viral vectors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

formulation developmentbiopharmaceutical formulationbiologic stabilitylyophilization servicesfreeze-dryingcontract research organizationCROCDMOviral vector formulationvaccine formulationadvanced therapy medicinal productsATMPsAI for drug formulationstability studiesbioinformatics servicesexcipient selectionprimary packaging services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Leukocare Comps

Public and private peers based on sector, stage, and business model.

Leukocare comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Leukocare Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jun 23, 2021
VC Round	Jul 22, 2015

View all Funding Rounds

Key People

Founding team and executive leadership

Michael Scholl

CEO

Executive Team

Leukocare Investors

Notable investors and investment history

Leukocare investors
Investor	Rounds
LifeCare Partners	VC Round
Petrichor Healthcare Capital Management	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 7, 2026
Monthly visitors increased 93% MoM.
Nov 7, 2025
Monthly visitors grew 398% MoM, from 530 to 2.6K.

View all signals

Leukocare Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Leukocare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Leukocare's valuation, stock price, and market status.

Firmographic Details

HeadquartersGermany

Employee Range56

Year Founded2003

Last FundingJun 23, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.